Overview of Craniomandibular Osteopathy (CMO) in Dogs
Craniomandibular osteopathy (CMO) is a non-cancerous disorder that almost exclusively affects the bones of the head in dogs. It is also called mandibular periostitis, temporomandibular osteodystrophy or “lion jaw.”
The cause of CMO is believed to be hereditary. Terriers are prone to the disorder. West Highland white terriers are the most commonly reported breed to be affected with CMO, with Scottish terriers, cairn terriers, Boston terriers and bullterriers also having a higher than normal incidence. It has been reported in non-terrier breeds, but this is uncommon.
The age of onset of clinical signs is usually three to eight months. There is no sex predilection, with males and females affected equally. Neutering and spaying seems associated with reduced risk of the disorder.
The disorder is usually self-limiting, but may require medication to make the dog comfortable.
What to Watch For
Signs of craniomandibular osteopathy in Dogs may include:
Diagnosis of Craniomandibular Osteopathy (CMO) in Dogs
Treatment of Craniomandibular Osteopathy (CMO) in Dogs
Home Care and Prevention
Administer pain medications as prescribed and feed special diets as prescribed.
There are no specific preventive care measures. People seeking purebred terriers, especially West Highland white terriers, should question breeders carefully about the occurrence of the disorder in any lines, as CMO is inherited in Westies, and is believed to be inherited in Scottish terriers as well.
In-depth Information on Canine Craniomandibular Osteopathy
Craniomandibular osteopathy (CMO) is a skeletal disease that occurs mainly in certain breeds of young terriers, although occasionally, non-terrier breeds are affected. The disease was first reported in England in 1958. When it affects large breeds, there is a greater tendency to show involvement of only the mandibles, and the condition seems to be less painful in large breeds.
There is no gender predilection, and males and females are affected equally. There is a tendency, however, for a reduction of the incidence of disease in dogs that are neutered or spayed.
Clinical signs usually develop when the dog is between 3 and 8 months of age, although there have been cases as young as two weeks and as old as 11 months. The cause of the disorder remains unknown, although there is evidence that the disease is inherited in West Highland white terriers, and possibly other terrier breeds.
Dogs with the disorder usually show signs of a swollen painful jaw, drooling, difficulty picking up food and pain on opening the mouth. Some dogs have an intermittent fever.
Severely affected dogs show atrophy of the muscles of mastication (chewing). X-rays are the main method of confirming the diagnosis. Both sides of the jaw are usually affected, although some dogs are affected only on one side. A biopsy may be necessary to confirm the diagnosis in breeds for which this disorder is uncommon, especially if only one side of the jaw is affected. The disorder usually resolves on its own, although anti-inflammatory drugs may help reduce some of the clinical signs. Occasionally, a dog is euthanized because of inability to relieve the extreme discomfort.
In-depth Information on Diagnosis
In-depth Information on Therapy
No satisfactory treatment trials have been done for CMO in dogs. The disease is usually self-limiting, with the progression of the disease slowing down at around 11 to 13 months of age. Sometimes, it is followed by a slow regression of the disorder, although radiographic abnormalities or impaired function may remain. Several drugs have been tried, however, with good response.
Follow-up Care for Dogs with Craniomandibular Osteopathy
Optimal treatment for your dog requires a combination of home and professional veterinary care. Follow-up can be critical, especially if your pet does not rapidly improve. Administer all prescribed medication as directed. Alert your veterinarian if you are experiencing problems treating your dog.
Return to your veterinarian for follow-up radiographs, to monitor progression and/or resolution of the disorder.
The prognosis for affected dogs is guarded when extensive bone changes are present and are affecting the tympanic bullae and petrous temporal bone area. These animals may develop fusion of bones in this area, permanently restricting or preventing jaw movements and hindering the act of eating. The prognosis is better in dogs that are mildly affected. The disease often stops progressing around 11 to 13 months of age, and then may regress partially or completely.